Overview
GCP Global Auditor Certification is the essential credential for international auditors working in the global clinical research industry. This certification validates your expertise in conducting audits across multiple regulatory frameworks, including ICH E6(R3), Health Canada Division 5, and FDA regulations. As an international auditor, you must navigate complex regulatory requirements across jurisdictions and ensure that clinical trials are conducted in compliance with global standards. This guide provides a comprehensive overview of the certification process, the skills you will develop, and the training programs available to help you succeed.
Why GCP Global Auditor Certification is Essential for International Auditors
GCP Global Auditor Certification is essential for international auditors for several reasons:
- Demonstrating Global Competence – validating your knowledge of multiple regulatory frameworks
- Enhancing International Career Opportunities – making you more competitive for global roles
- Ensuring Cross-Jurisdictional Compliance – enabling you to conduct audits across multiple countries
- Supporting Global Clinical Trials – addressing the challenges of multi-regional trials
- Building Professional Credibility – gaining recognition as an international auditing expert
What International Auditors Need to Know
International auditors must master several key areas, including:
- Regulatory Frameworks – ICH E6(R3), Health Canada Division 5, FDA 21 CFR Parts 50, 56, 312, 314.50, and 314.80
- Auditing Practices – based on ISO 19011:2026 including seven auditing principles
- Audit Programme Management – objectives, risks, resources, procedures, implementation, monitoring, review, and improvement
- Remote Auditing Methods – virtual audits, technology considerations, security, and contingency planning
- Competence and Evaluation of Auditors – personal behaviour, knowledge and skills, evaluation methods, and maintaining competence
Detailed Course Breakdown
Course 1: GCP Global Auditor Certification Program
This training program defines the complete knowledge and performance requirements for personnel involved in clinical research to become certified global auditors for Good Clinical Practice (GCP).
Scope: The program integrates GCP requirements from ICH E6(R3), Health Canada Part C, Division 5 of the Food and Drug Regulations, and FDA regulations (21 CFR Parts 50, 56, 312, 314.50, and 314.80) with auditing practices based on ISO 19011:2026 for internal, second-party (vendor/CRO/site audits), and global regulatory compliance auditing.
Description of Modules: The curriculum covers comprehensive sections on:
- Regulatory Frameworks including ICH E6(R3), Health Canada Division 5, and FDA 21 CFR Parts 50, 56, 312, 314
- Auditing Practices based on ISO 19011:2026 including seven auditing principles
- Audit programme management including objectives, risks, resources, procedures, implementation, monitoring, review, and improvement
- Conducting an audit from initiation, preparation, execution, reporting, to follow-up
- Remote auditing methods including virtual audits, technology considerations, security, and contingency planning
- Competence and evaluation of auditors including personal behaviour, knowledge and skills, evaluation methods, and maintaining competence
Target Audience:
- Quality Assurance Personnel
- Clinical Research Associates (Monitors)
- Study Directors and Clinical Trial Managers
- Clinical Investigators and Site Staff
- Sponsor Personnel
- CRO Personnel
- IRB/IEC Members and Coordinators
- Data Management and Biostatistics Professionals
- Pharmacovigilance and Safety Specialists
- Regulatory Affairs Professionals
- Global Clinical Trial Managers
- Audit Program Managers
Pricing: $499.00 with group discounts available.
FAQ:
- What are the prerequisites for the GCP Global Auditor Certification? Completion of basic GCP awareness training of at least four hours or equivalent on-the-job experience, plus at least six months of experience in clinical research.
- What is ISO 19011:2026 and why is it important for international auditors? ISO 19011:2026 provides guidelines for auditing management systems, covering audit principles, programme management, conduct, remote methods, and competence evaluation.
- What are the seven principles of auditing? The seven principles are integrity, fair presentation, due professional care, confidentiality, independence, evidence-based approach, and risk-based approach.
- What regulatory frameworks are covered in this program? The program covers ICH E6(R3), Health Canada Part C Division 5, and FDA 21 CFR Parts 50, 56, 312, 314.50, and 314.80.
- How does this certification support international auditing? It provides the knowledge and skills needed to conduct audits across multiple jurisdictions and regulatory frameworks.
Enroll Now: https://www.gxptrainings.com/courses/gcp-global-auditor-certification-program/
Course 2: Good Clinical Practices (ICH E6(R3) Focused)
This comprehensive training program provides an in-depth exploration of the ICH E6(R3) Good Clinical Practice guideline.
Scope: The curriculum is structured to guide participants through the entire guideline, covering the 11 fundamental principles, the expanded roles and responsibilities of sponsors and investigators, rigorous data governance frameworks, and the critical requirements for essential records.
Description of Modules: The curriculum covers:
- ICH E6(R3) overview and its significance in global clinical research
- 11 Fundamental Principles of GCP and their application
- Sponsor responsibilities including oversight and quality management
- Investigator responsibilities including delegation and supervision
- Informed consent requirements and documentation
- Data governance and integrity frameworks
- Essential records and Trial Master File requirements
- Safety reporting and pharmacovigilance obligations
- Risk-based approaches to trial management
- Digital technologies and decentralized trial elements
Target Audience:
- Clinical Investigators and Sub-Investigators
- Sponsor Personnel (Medical, Regulatory, Clinical Operations)
- Clinical Research Associates (Monitors)
- IRB/IEC Members and Coordinators
- Data Management and Biostatistics Professionals
- Quality Assurance and Compliance Staff
- Clinical Trial Coordinators and Site Staff
- Pharmacovigilance and Safety Specialists
- Regulatory Affairs Professionals
- Clinical Research Organization (CRO) Personnel
Pricing: $149.00 with group discounts available.
FAQ:
- How does ICH E6(R3) support international GCP auditing? It is the global standard for GCP, recognized across all major regulatory jurisdictions.
- What is the significance of ICH E6(R3) for international auditors? It provides the harmonized framework for GCP that auditors use to assess compliance globally.
- What are the 11 fundamental principles of GCP? The 11 fundamental principles cover the ethical and scientific foundation of clinical trials.
- How does ICH E6(R3) address risk-based approaches? It emphasizes proportionate and risk-based approaches to trial management.
- Why is ICH E6(R3) important for international auditors? It is the global standard for GCP, and auditors must be familiar with its requirements to assess compliance across jurisdictions.
Enroll Now: https://www.gxptrainings.com/courses/ich-e6r3-good-clinical-practices-gcp/
Course 3: Health Canada Good Clinical Practice Training
This comprehensive training program provides clinical research professionals with the knowledge and practical skills required to conduct clinical trials in compliance with Health Canada Food and Drug Regulations (Part C, Division 5) and the ICH E6(R3) GCP guideline.
Scope: The curriculum is aligned with Health Canada’s adoption of ICH E6(R3) effective April 1, 2026.
Description of Modules: The curriculum covers:
- Health Canada regulatory requirements for clinical trials (Part C, Division 5)
- ICH E6(R3) GCP principles and Annex 1
- Sponsor, Qualified Investigator, and REB responsibilities
- Clinical trial application (CTA) and amendment processes
- Informed consent requirements and participant protection
- Safety reporting obligations (AEs, SAEs, SUSARs)
- Data governance and record-keeping requirements
- Quality management and risk-based monitoring
- Investigational product management and GMP compliance
Target Audience:
- Sponsors (commercial and non-commercial/academic)
- Qualified Investigators (QIs) and Principal Investigators
- Research Ethics Board (REB) members and administrators
- Clinical Research Coordinators and study site personnel
- Contract Research Organizations (CROs) and Service Providers
Pricing: Competitive pricing with group discounts available.
FAQ:
- How does Health Canada GCP training support international auditing? It provides the regulatory knowledge needed to assess compliance with Canadian requirements.
- What is the role of the Qualified Investigator under Health Canada? The QI must be qualified by education, training, and experience.
- What are the requirements for informed consent under Health Canada? Informed consent must be obtained from all participants before trial participation.
- What is the Clinical Trial Application (CTA) process in Canada? Sponsors must submit a CTA to Health Canada for authorization.
- What is ALCOA+ and why is it important? ALCOA+ is a set of principles for ensuring data integrity.
Enroll Now: https://www.gxptrainings.com/courses/health-canada-good-clinical-practice-training/
Course 4: HIPAA Clinical Data Privacy, Security & Compliance Training
This training program provides organizations and individuals with a comprehensive understanding of the legal, regulatory, and operational requirements for protecting health information in clinical research and healthcare delivery settings.
Scope: The program covers the full spectrum of privacy, security, and compliance obligations under U.S. federal law and international good practice standards.
Description of Modules: The curriculum covers 10 comprehensive sections:
- HIPAA Overview and regulatory landscape
- HIPAA Privacy Rule requirements and PHI protections
- HIPAA Security Rule requirements and ePHI safeguards
- HIPAA Breach Notification Rule requirements
- GCP and clinical data integrity requirements
- Security controls for information systems and cloud environments
- Regulatory compliance frameworks including FDA, NIST, and ISO
- Incident management and breach response
- Risk assessment methodologies
- Roles and responsibilities of Sponsors, CROs, Investigators, and technology vendors
Target Audience:
- Covered Entities under HIPAA
- Business Associates and their subcontractors
- Clinical Research Professionals
- Security and Compliance Professionals
Pricing: $249.00 with group discounts available.
FAQ:
- Why is HIPAA training important for international GCP auditors? Auditors must verify that clinical trials comply with data privacy and security requirements.
- What is Protected Health Information (PHI)? PHI is health information that identifies an individual.
- What is the difference between the HIPAA Privacy Rule and Security Rule? The Privacy Rule protects the privacy of PHI, while the Security Rule establishes standards for protecting ePHI.
- What is a breach under HIPAA? A breach is the unauthorized acquisition, access, use, or disclosure of PHI.
- What is the role of a Business Associate Agreement? It establishes the terms for PHI handling and protection between a covered entity and a business associate.
Enroll Now: https://www.gxptrainings.com/courses/hipaa-clinical-data-privacy-security-compliance-training/
Course 5: Certified Regulatory Affairs Professional (CRAP)
This comprehensive certification program provides regulatory professionals with end-to-end knowledge of the global pharmaceutical regulatory landscape.
Scope: The program covers the complete drug development lifecycle from discovery through post-approval lifecycle management.
Description of Modules: The curriculum covers:
- Global Regulatory Framework overview
- Investigational New Drug (IND) applications
- New Drug Applications (NDA) for innovative pharmaceuticals
- Abbreviated New Drug Applications (ANDA) for generics
- Biologics License Applications (BLA) for biological products
- Orphan Drug Designation for rare disease treatments
- Special Programs including Accelerated Approval and Breakthrough Therapy
- Post-approval lifecycle management
- Regulatory agency interactions and meeting management
- Global regulatory strategy development
Target Audience:
- Regulatory Affairs Professionals
- Pharmaceutical Development and Formulation Scientists
- Quality Assurance/Quality Control Professionals
- Clinical and Nonclinical Development Professionals
Pricing: $799.00 with group discounts available.
FAQ:
- How does regulatory affairs training support international GCP auditing? Understanding global regulatory requirements helps auditors assess compliance across jurisdictions.
- What is the difference between an IND and an NDA? An IND authorizes clinical trials, while an NDA requests marketing approval.
- What is the eCTD format and why is it important? eCTD is the standard format for regulatory submissions.
- What is the purpose of an Orphan Drug Designation? It provides incentives for developing drugs for rare diseases.
- What is the role of ICH in global drug development? ICH harmonizes regulatory requirements across regions.
Enroll Now: https://www.gxptrainings.com/courses/certified-regulatory-affairs-professional/
Get Your Team Offer
For organizations looking to enroll multiple participants, we offer specialized team packages and volume discounts. Please reach out to our partnership team to discuss your specific needs and scores.
Contact Us: https://www.gxptrainings.com/contact-us/
Authors
